Professional Documents
Culture Documents
Internal Ward 2
Internal Ward 2
I. ASSESSMENT
Treating Physician (Qualification):
Pharmacist: No
A. PATIENT’S DEMOGRAPHIC DETAILS
Name Kelifa shafi
Gender male
Age 27
Weight
Height
BMI
Card Number 0086468
Pregnancy and breast
feeding
Occupation police
Living condition poor
Address Adiss abeba
Room and bed 817/2
Religion Muslim
Date of admission 29/7/15
Patient stay 8
B. PATIENT’S CLINICAL INFORMATION
chiefe compliant
Physicians diagnosis Ankle joint dislocation
History of present Ankle joint dislocation
illness
RBC
MCV
MCH 31.9 H
MCHC
Hct
Hgb
Lymphocytes
Neutrophils
SCr
ESR
SGOT
SGPT
U/A Protein
Glucose
Ketone
WBC
RBC
Epithelial cells
Glomerular casts
V/S BP 110/70
Temperature 36.9
RR
PR 88
Family history There is no any other disease in his family
Social history No smoking
C. Current Medication Record
Date 29/7/15 Ceftriaxone 1g iv bid
Heparin 7500 iv bid
Diclofenac 75mg I'm PRN
Clinical parameters for effectiveness evaluation: Improvement in pain but no the diseaee
Clinical parameters for safety evaluation:No undesirable effects of drug therapy
Laboratory parameters for effectiveness evaluation: there is no improvement in indicators of the
disease
Laboratory parameters for safety evaluation: No indicators of harmful effects of drug therapy
FOLLOW-UP RESULTS
Treat the pain but still Ankle joint dislocated so continious therapy needed
Medical condition II: Ankle joint dislocated
Symptoms:- Relive pain
Signs:- Ankle joint dislocated
Goal of therapy: relaif pain and back the joint in to there area
Interventions: Initiate drug therapy and treat the joint
Counseling given: stay and treatd as Directed by Physician Until treated from this
Medical Current DTPs Therapeutic Therapeutic Rational Monitoring
Problem Drug Goals Recommendations
Regimen
Ankle Ceftriaxon No Treat pain Back the joint in to If no treated
joint Heparin and back the there area the joint
dislocatio Diclofenac joint in to unable to
n injections your area walking so
treated the
joint
FOLLOW-UP PARAMETERS
Clinical parameters for effectiveness evaluation: improved pain
Clinical parameters for safety evaluation: There is no undesirable effect of drug therapy
Laboratory parameters for effectiveness evaluation: There is no improvement of in indicators of the
disease
Laboratory parameters for safety evaluation: There are no indicators of harmful effects of drug therao y
FOLLOW UP RESULTS
The stages of wound healing are a complex and fragile process. Failure to progress in the stages of wound
healing can lead to chronic wounds. Factors that lead up to chronic wounds are venous disease, infection,
diabetes and metabolic deficiencies of the elderly. Careful wound care can speed up the stages of wound
healing by keeping wounds moist, clean and protected from reinjury and infection. follow up results there
are non-dissolvable stitches or staples, health provider provider will remove them within 3 to 21 days also
a segmental fractures and it will treated by surgery resting and icing the affected area, followed by
controlled exercises that help restore range of motion, improve muscle strength and promote bone
healing.
Remodeling or also known as maturation phase is the last and final phase in wound healing and lasts
from 21 days up to 2 years. In this final and longest phase, collagen synthesis is ongoing in order to
strengthen the tissue. Remodeling occurs as wound continues to contract and fibers are being reorganized.
Recommendation
Treat the pateint fully from that pain and until he start walking